About
Exit readiness is built through years of operating and go-to-market decisions, not only when a transaction begins. Customer mix, revenue quality, intellectual property, leadership, and integration readiness can all influence future buyer interest. This workshop reviews common exit paths and what strategic and financial buyers value in healthcare companies. Through practical transaction and growth examples, participants will learn how to connect today’s commercial choices with long-term company value and prepare the business for diligence and integration. You’ll learn how to: 🚪 Identify strategic sales, financial buyers, mergers, buyouts, IPOs, and other exit paths 🔍 Evaluate what different buyer types value 💵 Connect recurring revenue and customer quality to company attractiveness 🧠 Assess the value of IP, data, market position, and scalability 📁 Build cleaner legal, financial, operational, and ownership records 🧭 Apply exit goals to go-to-market and partnership decisions --------------------------------------------------------- David Peteler David is President of Peteler Advisors, where he helps entrepreneurs navigate growth, financing, M&A, exit planning, and business sales. A seasoned business and finance attorney, he brings more than 30 years of experience advising technology and growth-stage companies. Demi Radeva, MSc Demi is the founder of Akros Advisory and a former UnitedHealthcare and Optum leader across Medicaid, Medicare, and Commercial health plans. She has supported 50+ HealthTech startups with payer strategy, market access, funding, and payer contracts. --------------------------------------------------------- Best for: Healthcare founders, CEOs, investors, board members, growth leaders, and teams preparing a company for acquisition, financing, or another exit path